Finance

Results: 23533-23544 of 39891

DeFi Technologies Subsidiary Valour launches Asset-backed Ethereum Physical Staking ETP for Professional Investors on the London Stock Exchange

"Charming Beijing" Exhibition kicked off in Amsterdam, the Netherlands on 28th Sept., celebrates the 30th anniversary of the sister city relationship between Beijing and Amsterdam. (Photo: Business Wire)

“Charming Beijing” Exhibition Highlights World Cultural Heritage for European Audiences

Global mayors exchange ideas in Hangzhou on sustainable urban development

PR Newswire associated0

Systems Spray-Cooled receives order from Danieli

Technology Industry Leaders to Tackle AI, Data Privacy and More at ISACA Conference Europe

Baladna Signs Agreement with Algerian National Investment Fund for Dairy and Milk Powder Production and MoU for Infant Milk Project (Photo: AETOSWire)

Baladna Signs Agreement with Algerian National Investment Fund for Dairy and Milk Powder Production and MoU for Infant Milk Project

Opening session of the EUMETSAT Meteorological Satellite Conference 2024, with EUMETSAT Director-General Phil Evans on screen (Photo: Business Wire)

EUMETSAT: European and Global Weather and Climate Experts Gather in Würzburg

Protest against the President: Tunisian demonstrators attend a rally against President Kais Saied, called by the opposition “National Salvation Front” coalition, in the capital Tunis, on April 9, 2023.

Tunisia's democratic dream is at risk as the country’s economy struggles

(Graphic: Business Wire)

FPT Software Wins Job Creation Award at ESGBusiness Awards 2024

PR Newswire associated0

AV-Comparatives Announces Outstanding Results of Cybersecurity Solutions in 2024 Endpoint Prevention and Response (EPR) Test

Natra has acquired Gudrun, a leader in the development, production, packaging and commercialisation of real Belgian chocolates and truffles. (Photo: Business Wire)

Belgian Chocolate Maker Gudrun Joins Natra to Create a Leading Global Chocolate and Sweets Platform

Primary Endpoint Met in Phase 3 Comparative Clinical Study of Perjeta® (pertuzumab) Biosimilar Candidate HLX11